| 12:21p | Barclays Adjusts AbbVie's Price Target to $133 from $118, Keeps Equalweight Rating | MT |
| 08:55a | Opko Health, Pfizer Secure Japan's Approval for Pediatric Growth Hormone Deficiency Dru.. | MT |
| 06:49a | EMA Says Spikevax Product Information To Be Updated To Include Paraesthesia As Rare Sid.. | RE |
| 06:00a | Africa CDC to Seek Supplies of Merck & Co.'s COVID-19 Pill | MT |
| 04:47a | Arecor Therapeutics Initiates Early-Stage Clinical Trial for Insulin Formation | MT |
| 04:40a | Dozens of firms to make cheap version of Merck COVID pill for poorer nations | RE |
| 04:34a | Pfizer Secures $2.05 Billion US Army Contract Modification | MT |
| 03:43a | Credit Suisse Vice Chair Yet To Decide About Reelection At April Meeting | MT |
| 03:19a | Credit Suisse Vice Chairman Unsure Whether He Will Stay on Board, Tages-Anzeiger Report.. | DJ |
| 01/19 | Unilever ADRs Bounce Back After Co. Commits to Financial Discipline | DJ |
| 01/19 | Unilever Says It Won't Raise Offer for GSK Consumer Health Division | DJ |
| 01/19 | Essa Pharma Commences Dosing in Phase 1/2 Clinical Trial of Prostate Cancer Combo Thera.. | MT |
| 01/19 | Valneva Shares Suffer as Coronavirus Vaccine Seen Arriving Too Late | DJ |
| 01/19 | GlaxoSmithKline Names Chief Scientific Officer Designate | MT |
| 01/18 | S&P Flags Unilever for Downgrade on Proposal to Buy GSK/Pfizer's Consumer Healthcare Ar.. | MT |
| 01/18 | Fourth Pfizer-BioNTech COVID-19 Shot Fails to Prevent Omicron Infection in Israeli Stud.. | MT |
| 01/18 | Pfizer Seeks Swissmedic's Nod For COVID-19 Treatment Paxlovid | MT |
| 01/18 | Consumer Stocks Hit Hard in Tuesday Selloff | MT |
| 01/18 | Consumer Stocks Falling Tuesday, Led Lower By Cyclicals | MT |
| 01/18 | Cowen Adjusts AbbVie's Price Target to $150 From $130, Keeps Outperform Rating | MT |
| 01/18 | I-Mab Doses First Patient in Mid-Stage Lemzoparlimab Combo Trial in Advanced Solid Tumo.. | MT |
| 01/18 | GSK Says Rejected $68 Billion Unilever Bid for Consumer Healthcare Unit in Favor of Spi.. | MT |
| 01/18 | Unilever ADRs Drop After Approach for Glaxo's Consumer-Health Business | DJ |
| 01/18 | European Medicines Agency Says mRNA COVID-19 Vaccines Safe In Pregnancy | MT |
| 01/18 | Loblaw and Imperial Say Loyalty Program Now Valid at Esso Stations; Select Pharmacies W.. | MT |
| 01/18 | Consumer Stocks Lower Tuesday Pre-Bell | MT |
| 01/18 | Consumer | MT |
| 01/18 | Sema4 Agrees to Acquire OPKO Health Subsidiary GeneDx for $623 Million | MT |
| 01/18 | Canadian Regulator Approves Pfizer's COVID-19 Treatment Paxlovid | MT |
| 01/18 | Pfizer Adds Novasep to Global Supply Chain for Paxlovid Pill | MT |
| 01/17 | Canadian Regulator Approves Use of Pfizer Oral Drug for Covid-19 | DJ |
| 01/17 | Health Canada To OK Pfizer's COVID-19 Antiviral Pill | MT |
| 01/17 | ROCHE HOLDINGS AG : Buy rating from Deutsche Bank | MD |
| 01/17 | Unilever to Initiate Major Restructuring Plan Amid Intent to Buy GSK/Pfizer's Consumer .. | MT |
| 01/17 | Unilever Looking to Reposition Portfolio After GSK Consumer Healthcare Approach -- Upda.. | DJ |
| 01/17 | Midatech Pharma, Janssen Extend R&D Partnership On Experimental Medicine | MT |
| 01/17 | Unilever Seeks to Accelerate Growth Via GSK-Pfizer's Consumer Healthcare Unit Buy | MT |
| 01/17 | Pfizer To Inject $594 Million For France's COVID-19 Plans; Teams Up To Develop COVID-19.. | MT |
| 01/17 | Macron touts rosy French economy, new jobs ahead of election | RE |
| 01/16 | Unilever Seeks Additional Funding to Sweeten $68 Billion Bid to Buy GSK/Pfizer's Consum.. | MT |
| 01/16 | GlaxoSmithKline, Pfizer Seek At Least $82 Billion For Consumer Healthcare Arm | MT |
| 01/15 | Factbox-GSK's consumer health business | RE |
| 01/14 | FDA Approves Pfizer's CIBNOQ For Adults With Moderate-to-Severe Atopic Dermatitis | MT |
| 01/14 | U.S. FDA Approves Pfizer’s CIBINQO® (abrocitinib) for Adults with Moderate-to-Seve.. | CI |
| 01/14 | AbbVie Gets FDA Approval for Rinvoq for Ages 12 and Older | DJ |
| 01/14 | AbbVie Says FDA Approves Rinvoq to Treat Atopic Dermatitis | MT |
| 01/14 | U.S. FDA Approves RINVOQ® (upadacitinib) to Treat Adults and Children 12 Years and Olde.. | CI |
| 01/14 | Novo Nordisk Settles Securities Case in Denmark | MT |
| 01/14 | BMO Capital Adjusts Pfizer's Price Target to $76 From $60, Keeps Outperform Rating | MT |
| 01/14 | European Medicines Agency Asks AstraZeneca, Johnson & Johnson To Add Spinal Inflammatio.. | MT |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
